Aarsland D et al (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47

Article  PubMed  Google Scholar 

Abrishamdar M, Jalali M, Rashno M (2022) MALAT1 lncRNA and Parkinson’s disease: the role in the pathophysiology and significance for diagnostic and therapeutic approaches. Mol Neurobiol 59(9):5253–5262

Article  PubMed  CAS  Google Scholar 

Abubakar I, Tillmann T, Banerjee A (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117–171

Article  Google Scholar 

Abuhamdah S et al (2015) Pharmacological and neuroprotective profile of an essential oil derived from leaves of A loysia citrodora Palau. J Pharm Pharmacol 67(9):1306–1315

Article  PubMed  CAS  Google Scholar 

Aditya Rao SJ, Shetty NP (2024) Advances in designing next-generation drugs from natural products. Authorea Preprints

Aguiar AS et al (2016) Moderate-intensity physical exercise protects against experimental 6-hydroxydopamine-induced hemiparkinsonism through Nrf2-antioxidant response element pathway. Neurochem Res 41:64–72

Article  PubMed  CAS  Google Scholar 

Akki AJ et al (2024) Advances in Parkinson’s disease research–a computational network pharmacological approach. Int Immunopharmacol 139:112758

Article  PubMed  CAS  Google Scholar 

Alhebshi A et al (2014) Thymoquinone protects cultured hippocampal and human induced pluripotent stem cells-derived neurons against α-synuclein-induced synapse damage. Neurosci Lett 570:126–131

Article  PubMed  CAS  Google Scholar 

Ali DE et al (2023) HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson’s disease in rats. PLoS ONE 18(2):e0282246

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ali D et al (2024) Implications of herbal components in the treatment of neurological disorders. Curr Nutr Food Sci 20(6):677–686

Article  CAS  Google Scholar 

Alikatte K et al (2021) Fisetin improved rotenone-induced behavioral deficits, oxidative changes, and mitochondrial dysfunctions in rat model of Parkinson’s disease. J Diet Suppl 18(1):57–71

Article  PubMed  CAS  Google Scholar 

Alosaimi F et al (2022) The role of neurotransmitter systems in mediating deep brain stimulation effects in Parkinson’s disease. Front Neurosci 16:998932

Article  PubMed  PubMed Central  Google Scholar 

Anis E et al (2020) Ferulic acid reinstates mitochondrial dynamics through PGC1α expression modulation in 6-hydroxydopamine lesioned rats. Phytother Res 34(1):214–226

Article  PubMed  CAS  Google Scholar 

Antunes MS et al (2014) Protective effect of hesperidin in a model of Parkinson’s disease induced by 6-hydroxydopamine in aged mice. Nutrition 30(11–12):1415–1422

Article  PubMed  CAS  Google Scholar 

Anusha C, Sumathi T, Joseph LD (2017) Protective role of apigenin on rotenone induced rat model of Parkinson’s disease: suppression of neuroinflammation and oxidative stress mediated apoptosis. Chem Biol Interact 269:67–79

Article  PubMed  CAS  Google Scholar 

Apetauerova D et al (2016) CoQ10 in progressive supranuclear palsy: a randomized, placebo-controlled, double-blind trial. Neurol: Neuroimmunol Neuroinflam 3(5):e266

Ardah MT et al (2015) Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiol Dis 74:89–101

Article  PubMed  CAS  Google Scholar 

Ardah MT, Merghani MM, Haque ME (2019) Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro. Neurochem Int 128:115–126

Article  PubMed  CAS  Google Scholar 

Ardah MT et al (2020) Ellagic acid prevents dopamine neuron degeneration from oxidative stress and neuroinflammation in MPTP model of Parkinson’s disease. Biomolecules 10(11):1519

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aspatwar A et al (2024) Herbal-based nanosystems: a novel drug-delivery treatment procedure against neurodegenerative disorders. ChemRxiv preprints

Attia HN, Maklad YA (2018) Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson’s disease in experimental animals. Behav Pharmacol 29(1):79–86

Article  PubMed  CAS  Google Scholar 

Ay M et al (2017) Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson’s disease. J Neurochem 141(5):766–782

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ba Q et al (2015) Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson’s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed Pharmacother 75:165–172

Article  PubMed  CAS  Google Scholar 

Badshah H et al (2019) Caffeine may abrogate LPS-induced oxidative stress and neuroinflammation by regulating Nrf2/TLR4 in adult mouse brains. Biomolecules 9(11):719

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bagwell E, Larsen J (2024) A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson’s disease. Front Neurosci 18:1451845

Article  PubMed  PubMed Central  Google Scholar 

Balakrishnan R et al (2021) Natural phytochemicals as novel therapeutic strategies to prevent and treat Parkinson’s disease: current knowledge and future perspectives. Oxid Med Cell Longev 2021:1–32

Article  Google Scholar 

Baluchnejadmojarad T et al (2017) Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson’s disease: possible involvement of ERβ/Nrf2/HO-1 signaling. Brain Res 1662:23–30

Article  PubMed  CAS  Google Scholar 

Bandres-Ciga S et al (2020) Genetics of Parkinson’s disease: an introspection of its journey towards precision medicine. Neurobiol Dis 137:104782

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beal MF et al (2014) A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol 71(5):543–552

Article  PubMed  Google Scholar 

Behl T et al (2021) Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives. Int J Mol Sci 22(3):1413

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bennett CF, Latorre-Muro P, Puigserver P (2022) Mechanisms of mitochondrial respiratory adaptation. Nat Rev Mol Cell Biol 23(12):817–835

Article  PubMed  PubMed Central  CAS  Google Scholar 

Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson’s disease. BioEssays 24(4):308–318

Article  PubMed  CAS  Google Scholar 

Bloem BR, Okun MS, Klein C (2021) Parkinson’s disease. The Lancet 397(10291):2284–2303

Article  CAS  Google Scholar 

Blum D et al (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65(2):135–172

Article  PubMed  CAS  Google Scholar 

Booth S (2024) Limitations in effective treatment of Parkinson’s disease: neuroanatomical substrate of L-Dopa induced dyskinesia and cognitive impairment [Doctoral d